Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis

PURPOSE: In the integrated analysis of phase III head-to-head trials in patients with advanced solid tumors, denosumab demonstrated superiority over zoledronic acid in preventing skeletal-related events (SREs). Regular and continued drug use (persistence) is a precondition of clinical efficacy; pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslbauer, Ferdinand, Petzer, Andreas, Safanda, Martin, Tomova, Antoaneta, Porubska, Miriam, Bajory, Zoltán, Niepel, Daniela, Jaeger, Christine, Bjorklof, Katja, Kalinin, Dmitry, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036060/
https://www.ncbi.nlm.nih.gov/pubmed/31350601
http://dx.doi.org/10.1007/s00520-019-04988-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036060/
https://www.ncbi.nlm.nih.gov/pubmed/31350601
http://dx.doi.org/10.1007/s00520-019-04988-7

Ejemplares similares